ClinicalTrials.Veeva

Menu
V

Velocity Clinical Research | Binghamton, NY

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Bupropion Hydrochloride
QCZ484
Evinacumab
Naltrexone Hydrochloride

Parent organization

This site is a part of Velocity Clinical Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 5 total trials

A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients

The purpose of this study is to evaluate the efficacy, safety and tolerability of QCZ484 or placebo, given subcutaneously, every 6 months, at differe...

Active, not recruiting
Hypertension
Drug: QCZ484
Other: Saline

A randomized, double-blinded, placebo controlled study intended to capture cardiovascular outcomes during real-world use of naltrexone/bupropion (NB).

Active, not recruiting
Obesity
Drug: Placebo
Drug: Naltrexone-Bupropion (NB) Combination

This study is researching an experimental drug called ALN-ANG3 (called "study drug"). The study is focused on participants who have diabetic kidney d...

Enrolling
Diabetic Kidney Disease (DKD)
Drug: Evinacumab
Drug: ALN-ANG3

Trial sponsors

C
Moderna logo
Novartis logo
Novavax logo
Regeneron Pharmaceuticals logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems